Cargando…
Immune cell profiling and antibody responses in patients with COVID-19
BACKGROUND: Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets’ analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducte...
Autores principales: | Rezaei, Mitra, Mahmoudi, Shima, Mortaz, Esmaeil, Marjani, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256640/ https://www.ncbi.nlm.nih.gov/pubmed/34225645 http://dx.doi.org/10.1186/s12879-021-06278-2 |
Ejemplares similares
-
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm
por: Mahmoudi, Shima, et al.
Publicado: (2020) -
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
Evaluation of Lymphocyte Subtypes in COVID-19 Patients
por: Rezaei, Mitra, et al.
Publicado: (2022) -
Bruton's Tyrosine Kinase: A Promising Target for the Treatment of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2020) -
The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020)